Enfusion (NYS: ENFN), the cloud-based portfolio management and risk systems software provider for investment funds, has drawn attention from private equity buyers as a potential takeover target. Francisco Partners, Vista Equity Partners, and investment firm Irenic Capital Management LP have reportedly been in discussions with the Enfusion team regarding a potential acquisition.
Like many other technology companies that went public at the height of the pandemic bull market, Enfusion’s stock lost over half its value since its IPO in 2021. On June 26th, Enfusion’s shares rose 19.9% on the back of the reports, closing the day at $11.04.
